Publicaciones científicas
Antimyoclonic action of piracetam
01-jun-1986
| Revista: Clinical Neuropharmacology
Obeso JA, Artieda J, Luquin MR, Vaamonde J, Martínez Lage JM.
Five patients with myoclonus were treated with oral piracetam (8-9 g/day). All patients had action-sensitive and/or stimulus-sensitive myoclonus and enhanced amplitude of somatosensory evoked potentials.
Piracetam produced a marked reduction of the myoclonus in the five subjects without side effects. In view of its excellent tolerance and synergism with other antimyoclonic drugs, we consider piracetam to be a very valuable drug for the treatment of patients with myoclonus of any origin.
CITA DEL ARTÍCULO Clin Neuropharmacol. 1986;9(1):58-64
Nuestros autores
